1. Ellison DW, McLendon R, Wiestler OD, et al. Ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors., et al., WHO classification of tumours of the central nervous system, revised. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 106–11.
2. Ellison DW, McLendon R, Wiestler OD, et al. Anaplastic ependymoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors., et al., WHO classification of tumours of the central nervous system, revised. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 113–4.
3. Pajtler KW, Witt H, Sill M, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell. 2015;27:728–43.
4. Ellison DW, Korshunov A, Witt H. Ependymoma, RELA fusion-positive. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system, revised. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 112.
5. Gessi M, Giagnacovo M, Modena P, et al. Role of immunohistochemistry in the identification of supratentorial C11orf95-RELA fused ependymoma in routine neuropathology. Am J Surg Pathol. 2019;43:56–63.